Clinical trial
A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher…
NCT00433147 · Amicus Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00433147 |
|---|---|
| Title | A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy |
| Official title | A Randomized, Open-label Study to Assess the Safety and Tolerability of Multiple Dose Levels and Multiple Dosing Regimens of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy |
| Lead sponsor | Amicus Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher Disease, Type 1, Type 1 Gaucher Disease |
| Intervention type | Drug |
| Interventions | Afegostat tartrate |
| Enrollment | 30 |
| Start date | Mar 23, 2007 |
| Primary completion | Feb 19, 2008 |
| Completion | Feb 19, 2008 |
| First posted | Feb 9, 2007 |
| Last update posted | Sep 25, 2018 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: